U.S. Residential REITs Stock News

If you have been eyeing Workday stock lately and wondering whether now is the right time to make a move, you are not alone. Plenty of investors are weighing Workday’s recent price fluctuations and trying to figure out how much growth might be left in the tank. After all, the stock’s journey over the last few months has been anything but boring. In the past 30 days, Workday fell about 4.8%, and for the year to date, it is down nearly 9.6%. Despite those recent dips, its three-year total return...

In August 2025, Kinder Morgan reported that its project backlog rose to US$9.3 billion as strong customer commitments, particularly in natural gas transportation for LNG exports, continued to drive demand. The company also initiated a binding open season for a potential expansion of its El Paso-Tucson refined products pipeline, offering new growth opportunities in an evolving energy infrastructure market. We'll explore how Kinder Morgan’s expanded project backlog underscores shifts in its...

Thinking about what to do with CVS Health stock right now? You are definitely not alone. Whether you are holding, buying, or just watching from the sidelines, CVS is drawing renewed attention from investors looking for a smart place to park their money. The company has posted a 7% gain over the past week and a solid 17% jump in the last month. Its year-to-date return is an impressive 61.5%. That is a noticeable turnaround when you consider how the overall healthcare sector has performed and...

Cellebrite DI Ltd. recently reported earnings for the half year ended June 30, 2025, showing revenue of US$220.83 million, a return to net income of US$36.88 million, and issued new guidance alongside the formal appointment of Thomas E. Hogan as CEO. The combination of significantly improved financial performance and the confirmation of an experienced leader at the helm highlights renewed momentum and confidence in Cellebrite's growth trajectory. We will now explore how Cellebrite’s sharp...

Alkami Technology recently announced that a top 20 U.S. credit union selected Alkami as its digital banking provider, adding at least 350,000 users to its implementation backlog and expanding adoption to nearly the entire Data & Marketing Solution suite. This win means Alkami now serves five of the top 20 credit unions, further reinforcing its position as the leading digital banking provider by mobile user market share among U.S. credit unions, according to FI Navigator. We'll explore how...

CleanSpark, Inc. ( NASDAQ:CLSK ) shareholders won't be pleased to see that the share price has had a very rough month...

Vipshop Holdings recently announced its second-quarter 2025 financial results, reporting revenue of CNY 25.81 billion and net income of CNY 1.49 billion, both lower than the prior year, along with progress on a major share buyback program and new third-quarter revenue guidance anticipating up to 5% year-over-year growth. While earnings and revenue both declined compared to the same period last year, the company's substantial share repurchases and cautious revenue outlook signal efforts to...

If you are eyeing NIKE stock and wondering if this is the moment to buy, sell, or just watch from the sidelines, you are not alone. In the past three months, NIKE’s share price has jumped about 27% after a bumpy few years, hinting at renewed optimism. However, that turnaround comes on the back of some notable company changes, such as a shake-up in leadership at Converse and delayed launches like the much-anticipated collaboration with Kim Kardashian’s Skims brand. These headlines are part of...

Markel Group (MKL) caught the eye of investors this week as its share price slipped modestly, down roughly 2.6% over the past month, despite no single headline-making event triggering the movement. Still, for those weighing what to do with the stock, noticeable swings can act as a prompt to revisit the underlying story, especially with Markel’s reputation as a unique player in the insurance world. When a company like Markel moves without a clear catalyst, it often raises the question: is this...

Deciding whether General Dynamics is a buy, hold, or sell right now? You are not alone. With its long track record and strategic position in the defense sector, General Dynamics has always been a stock that turns heads during uncertain markets and periods of growth alike. Lately, the stock has been on a steady upward trajectory, gaining over 21% year-to-date and posting a 10% total return over the past year. Of course, those kinds of returns get investors talking. Just in the past month,...

Thinking about what to do with Mondelez International stock? You are not alone. Much like a box of their signature snacks, MDLZ has offered investors a mix of flavors lately: some sweet, some a bit salty. Over the last year, the stock price has experienced its share of twists. After climbing early in the year, Mondelez recently dipped about 11% over the past month, despite moderate year-to-date growth of 5.8%. This gives investors both an opportunity and a puzzle. Are these moves setting up a...

In August 2025, Credo Technology Group Holding Ltd. and Amphenol reached a license and settlement agreement, ending all patent disputes related to active electrical cable technology and promptly dismissing their lawsuits. This legal resolution removes a major source of uncertainty for Credo, enhancing operational clarity by eliminating potential litigation risks and expenses. We'll explore how settling ongoing patent disputes with Amphenol could influence Credo's long-term growth outlook and...

The The Goodyear Tire & Rubber Company ( NASDAQ:GT ) share price has fared very poorly over the last month, falling by...

Thinking about what to do with Axon Enterprise stock? You are in good company. Lately, investors have had plenty to cheer about as Axon's share price has seen a steady climb. In just the past month, AXON shares are up nearly 6%, adding to a remarkable 28% gain year-to-date. If you rewind a full year, the total return reaches an impressive 105%. That is not simply the market being generous, as Axon has been outpacing competitors and gaining attention for its innovative role in public safety...

Thinking About Gartner Stock? Here’s What You Need to Know If you are wondering whether it is finally time to take a closer look at Gartner, or if it is safer to wait on the sidelines, there has been plenty of recent activity to consider. Gartner’s stock has seen significant movement in recent years, with around 87% growth over five years. However, the company has faced more challenging conditions recently. Over the past year, shares are down nearly 49%, with similar pressure evident over...

Thinking about what to do with PPG Industries stock? You are not alone, and for good reason. PPG has recently shown some intriguing stock price movements, and investors are wondering if that signals an opportunity or a warning sign. Over the past month, shares have ticked down about 3%, even as the broader materials sector has seen plenty of ups and downs. Yet, despite the recent softness, PPG is still trading roughly 14% below the average analyst price target and a hefty 34.9% beneath its...

Ouster (OUST) is making headlines after landing a major contract to expand its BlueCity traffic management solution across more than a hundred intersections in Utah. Partnering with Econolite and working closely with the Utah Department of Transportation, this initiative builds on a promising pilot at a dozen sites and marks a significant step forward in modernizing the state’s traffic infrastructure. For investors, this five-year commitment not only signals increased revenue visibility but...

Earlier in August 2025, Telephone and Data Systems, Inc. lowered its full-year revenue guidance after releasing its second quarter results, which showed quarterly and year-to-date revenue declines versus the previous year despite a rise in quarterly net income. Although the company maintained its quarterly dividends and reported improved net income for the second quarter, ongoing revenue softness and downward guidance revision signal continued operational pressures as it transitions its...

Picking what to do with Trip.com Group stock is a classic investor’s puzzle. Is it time to hold, buy, or wait? The last year has been especially interesting. Shares are up over 50% in the past 12 months and have more than doubled if you stretch out to three or five years. Even with some recent bumps and the broader market’s volatility, Trip.com’s stock is up about 5% in the past month and over 2% in the last quarter. Still, the stock price has dipped year-to-date, which some see as just a...

Cirrus Logic recently announced an expanded collaboration with GlobalFoundries to jointly develop and commercialize next-generation BCD process and Gallium Nitride (GaN) chip technologies, with manufacturing capabilities in both the U.S. and overseas. This initiative aims to strengthen Cirrus Logic's mixed-signal product portfolio and support more resilient, geographically diverse semiconductor supply chains for customers in sectors such as smartphones, vehicles, and industrial...

Thinking about what to do with your Corning stock? You are not alone. Whether you are watching the ticker with cautious optimism or weighing up that next buy-and-hold move, there is plenty to unpack beneath Corning’s recent performance. The stock has posted a total return of over 61% in the past year, with major upward momentum, especially in the past three months, where it surged more than 34%. Year-to-date, Corning has climbed almost 39%, outpacing many other tech-adjacent companies. All...

NRG Energy (NRG) has caught the eye of investors this week after a sharp price reversal. The company’s stock, which cruised higher early this year, has cooled significantly in recent sessions. This has prompted a fresh round of questions about what comes next. While no major announcement or event appears to have caused the slide, the sudden shift is drawing attention to the underlying fundamentals and whether market sentiment is now overstating future risks or pricing in a period of slower...

If you’ve been keeping an eye on BeOne Medicines (ONC), the new approval from the European Commission may have caught your attention. The regulators just greenlit a film-coated tablet version of BRUKINSA, the company’s flagship treatment, designed to cut patients’ daily pill burden in half and make the experience less daunting. This is not a groundbreaking new indication. However, it could make a real difference in patient adherence, which could influence sales momentum across Europe. It is...

CAVA Group, Inc. ( NYSE:CAVA ) shareholders won't be pleased to see that the share price has had a very rough month...